BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Konrad FM, Neudeck G, Vollmer I, Ngamsri KC, Thiel M, Reutershan J. Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent. FASEB J 2013;27:3524-35. [PMID: 23699177 DOI: 10.1096/fj.13-228122] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Borea PA, Gessi S, Merighi S, Varani K. Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? Trends Pharmacol Sci 2016;37:419-34. [PMID: 26944097 DOI: 10.1016/j.tips.2016.02.006] [Cited by in Crossref: 154] [Cited by in F6Publishing: 141] [Article Influence: 25.7] [Reference Citation Analysis]
2 Strunk T, van Haren SD, Hibbert J, Pettengill M, Ozonoff A, Jans J, Schüller SS, Burgner D, Levy O, Currie AJ. Cyclic AMP in human preterm infant blood is associated with increased TLR-mediated production of acute-phase and anti-inflammatory cytokines in vitro. Pediatr Res 2020;88:717-25. [PMID: 31578034 DOI: 10.1038/s41390-019-0586-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Antonioli L, Csóka B, Fornai M, Colucci R, Kókai E, Blandizzi C, Haskó G. Adenosine and inflammation: what's new on the horizon? Drug Discovery Today 2014;19:1051-68. [DOI: 10.1016/j.drudis.2014.02.010] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 11.9] [Reference Citation Analysis]
4 Effendi WI, Nagano T, Kobayashi K, Nishimura Y. Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. Cells 2020;9:E785. [PMID: 32213945 DOI: 10.3390/cells9030785] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
5 Gonzales JN, Gorshkov B, Varn MN, Zemskova MA, Zemskov EA, Sridhar S, Lucas R, Verin AD. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2014;306:L497-507. [PMID: 24414256 DOI: 10.1152/ajplung.00086.2013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
6 Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. Adenosine and Inflammation: Here, There and Everywhere. Int J Mol Sci 2021;22:7685. [PMID: 34299305 DOI: 10.3390/ijms22147685] [Reference Citation Analysis]
7 Zheng XF, Chen DD, Zhu XL, Le Grange JM, Zhou LQ, Zhang JN. Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation. Pharmacol Res Perspect 2021;9:e00840. [PMID: 34327862 DOI: 10.1002/prp2.840] [Reference Citation Analysis]
8 Konrad FM, Meichssner N, Bury A, Ngamsri KC, Reutershan J. Inhibition of SDF-1 receptors CXCR4 and CXCR7 attenuates acute pulmonary inflammation via the adenosine A2B-receptor on blood cells. Cell Death Dis 2017;8:e2832. [PMID: 28542132 DOI: 10.1038/cddis.2016.482] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
9 Zygmunt M, Gołembiowska K, Drabczyńska A, Kieć-Kononowicz K, Sapa J. Anti-inflammatory, antioxidant, and antiparkinsonian effects of adenosine A2A receptor antagonists. Pharmacol Biochem Behav 2015;132:71-8. [PMID: 25735490 DOI: 10.1016/j.pbb.2015.02.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Azizi H, Rouhani N, Shaki F, Karimpour-Razkenari E, Ghazaeian M, Salehifar E, Saeedi M, Fallah S. Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial. Int Immunopharmacol 2021;101:108227. [PMID: 34666302 DOI: 10.1016/j.intimp.2021.108227] [Reference Citation Analysis]
11 Hendry BM, Stafford N, Arnold AD, Sangwaiya A, Manglam V, Rosen SD, Arnold J. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients. Pharmacol Res Perspect 2020;8:e00631. [PMID: 32715661 DOI: 10.1002/prp2.631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 de Campos Facchin BM, da Rosa JS, Luz ABG, Moon YJK, de Lima TC, Casoti R, Biavatti MW, Dalmarco EM, Fröde TS. Systemic Administration of Calea pinnatifida Inhibits Inflammation Induced by Carrageenan in a Murine Model of Pulmonary Neutrophilia. Mediators Inflamm 2020;2020:4620251. [PMID: 32410853 DOI: 10.1155/2020/4620251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Al Jaaly E, Zakkar M, Fiorentino F, Angelini GD. Pulmonary Protection Strategies in Cardiac Surgery: Are We Making Any Progress? Oxid Med Cell Longev 2015;2015:416235. [PMID: 26576223 DOI: 10.1155/2015/416235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 DiNicolantonio JJ, Barroso-Aranda J. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole. Med Hypotheses 2020;143:110051. [PMID: 32650197 DOI: 10.1016/j.mehy.2020.110051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Chen YM, Chiang WC, Lin SL, Tsai TJ. Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update. J Biomed Sci 2017;24:84. [PMID: 29132351 DOI: 10.1186/s12929-017-0390-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
16 Konrad FM, Bury A, Schick MA, Ngamsri KC, Reutershan J. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation. PLoS One 2015;10:e0121725. [PMID: 25909327 DOI: 10.1371/journal.pone.0121725] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
17 Ngamsri K, Fuhr A, Schindler K, Simelitidis M, Hagen M, Zhang Y, Gamper-tsigaras J, Konrad FM. Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1. Cells 2022;11:1094. [DOI: 10.3390/cells11071094] [Reference Citation Analysis]
18 Konrad FM, Zwergel C, Ngamsri KC, Reutershan J. Anti-inflammatory Effects of Heme Oxygenase-1 Depend on Adenosine A2A- and A2B-Receptor Signaling in Acute Pulmonary Inflammation. Front Immunol 2017;8:1874. [PMID: 29326725 DOI: 10.3389/fimmu.2017.01874] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
19 Vanderstocken G, Dvorkin-Gheva A, Shen P, Brandsma CA, Obeidat M, Bossé Y, Hassell JA, Stampfli MR. Identification of Drug Candidates to Suppress Cigarette Smoke-induced Inflammation via Connectivity Map Analyses. Am J Respir Cell Mol Biol 2018;58:727-35. [PMID: 29256623 DOI: 10.1165/rcmb.2017-0202OC] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Konrad FM, Braun S, Ngamsri K, Vollmer I, Reutershan J. Heme oxygenase-1 attenuates acute pulmonary inflammation by decreasing the release of segmented neutrophils from the bone marrow. American Journal of Physiology-Lung Cellular and Molecular Physiology 2014;307:L707-17. [DOI: 10.1152/ajplung.00145.2014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
21 Aslam M, Gündüz D, Troidl C, Heger J, Hamm CW, Schulz R. Purinergic Regulation of Endothelial Barrier Function. Int J Mol Sci 2021;22:1207. [PMID: 33530557 DOI: 10.3390/ijms22031207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Koppe SW. Obesity and the liver: nonalcoholic fatty liver disease. Transl Res. 2014;164:312-322. [PMID: 25028077 DOI: 10.1016/j.trsl.2014.06.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
23 Lee CF, Lai HL, Lee YC, Chien CL, Chern Y. The A2A adenosine receptor is a dual coding gene: a novel mechanism of gene usage and signal transduction. J Biol Chem 2014;289:1257-70. [PMID: 24293369 DOI: 10.1074/jbc.M113.509059] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]